Published in Bull Soc Chim Biol (Paris) on July 27, 1967
Mycobacterial lipids: selected topics. Bacteriol Rev (1972) 2.35
Lipids of putative relevance to virulence in Mycobacterium tuberculosis: phthiocerol dimycocerosate and the attenuation indicator lipid. Infect Immun (1974) 1.60
Intermediary metabolism of mycobacteria. Bacteriol Rev (1972) 1.25
Identification of phthiodiolone ketoreductase, an enzyme required for production of mycobacterial diacyl phthiocerol virulence factors. J Bacteriol (2005) 0.97
Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun (1974) 6.53
Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs. Proc Natl Acad Sci U S A (1977) 3.31
Modulation of the immune response by a synthetic adjuvant and analogs. Proc Natl Acad Sci U S A (1976) 2.82
The origin and function of some methyl groups in branched-chain fatty acids, plant sterols and quinones. Biochem J (1964) 2.56
Isolation and properties of a macromolecular, water-soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis. Proc Natl Acad Sci U S A (1972) 2.41
Granuloma formation induced in mice by chemically defined mycobacterial fractions. J Bacteriol (1969) 2.36
Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br (2011) 1.95
The mycobacterial cell wall. Pure Appl Chem (1971) 1.90
Adjuvant activity of monomeric bacterial cell wall peptidoglycans. Biochem Biophys Res Commun (1974) 1.82
Occurrence of D-alanyl-(D)-meso-diaminopimelic acid and meso-diaminopimelyl-meso-diaminopimelic acid interpeptide linkages in the peptidoglycan of Mycobacteria. Biochemistry (1974) 1.79
Immune response to sheep red blood cells in mice pretreated with mycobacterial fractions. Infect Immun (1971) 1.79
Cellular reaction in the footpad and draining lymph nodes of mice induced by mycobacterial fractions and BCG bacilli. Infect Immun (1971) 1.77
Meier-Gorlin syndrome: report of eight additional cases and review. Am J Med Genet (2001) 1.76
Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity. Infect Immun (1982) 1.73
Occurrence of N-glycolylmuramic acid in bacterial cell walls. A preliminary survey. Biochim Biophys Acta (1970) 1.73
Mutation update for the CSB/ERCC6 and CSA/ERCC8 genes involved in Cockayne syndrome. Hum Mutat (2010) 1.67
Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse. Int J Immunopharmacol (1979) 1.65
Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers. Biochem Biophys Res Commun (1976) 1.60
[Mass spectometry of glycolipids. I. Structure of the "cord factor" of Corynebacterium diphtheriae]. Eur J Biochem (1967) 1.58
[N-methylation of peptides by the method of Hakomori. Structure of mycoside Cbl]. Tetrahedron Lett (1968) 1.55
Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties. Mol Cell Biochem (1975) 1.55
Synthetic immunostimulants derived from the bacterial cell wall. J Med Chem (1980) 1.54
Isolation of mitogenic and adjuvant active fractions from various species of Nocardiae. Infect Immun (1975) 1.54
Cord factor and related trehalose esters. Chem Phys Lipids (1976) 1.52
Chemical structure of the cell wall of Mycobacterium smegmatis. I. Isolation and partial characterization of the peptidoglycan. Biochem Biophys Res Commun (1969) 1.48
Muramyl peptides: immunomodulators, sleep factors, and vitamins. Med Res Rev (1984) 1.40
Mitogenic effect of a water-soluble extract of Nocardia opaca: a comparative study with some bacterial adjuvants on spleen and peripheral lymphocytes of four mammalian species. J Immunol (1974) 1.40
Complex chromosomal rearrangements: origin and meiotic behavior. Hum Reprod Update (2011) 1.37
Preparation and biological properties of water-soluble adjuvant fractions from delipidated cells of Mycobacterium smegmatis and Nocardia opaca. Infect Immun (1973) 1.35
A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases. J Med Genet (2001) 1.34
Antimalarial activity of S-isobutyl adenosine against Plasmodium falciparum in culture. FEBS Lett (1978) 1.33
Immunotherapy of Cancer with Nonliving BCG and Fractions Derived from Mycobacteria: Role of Cord Factor (Trehalose-6, 6'-Dimycolate) in Tumor Regression. Infect Immun (1974) 1.31
Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis. Bone Marrow Transplant (2004) 1.29
Parathyroid hormone leads to the lysosomal degradation of the renal type II Na/Pi cotransporter. Proc Natl Acad Sci U S A (1998) 1.29
Inhibitory activity of sinefungin and SIBA (5'-deoxy-5'-S-isobutylthio-adenosine) on the growth of promastigotes and amastigotes of different species of Leishmania. FEBS Lett (1980) 1.28
Sulfolipid I of Mycobacterium tuberculosis, strain H37RV. Nature of the acyl substituents. Biochemistry (1971) 1.27
Stimulation of thymocyte mitogenic protein secretion and of cytostatic activity of mouse peritoneal macrophages by trehalose dimycolate and muramyldipeptide. Eur J Immunol (1980) 1.27
Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain. Am J Hum Genet (2000) 1.26
Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptides. J Med Chem (1982) 1.25
Mass spectrometry of plastoquinones. The structure of the plastoquinones B,C and D. Biochem Biophys Res Commun (1965) 1.24
The antifungal antibiotic sinefungin as a very active inhibitor of methyltransferases and of the transformation of chick embryo fibroblasts by Rous sarcoma virus. Biochem Biophys Res Commun (1978) 1.22
Antitrypanosomal activity of sinefungin. Am J Trop Med Hyg (1983) 1.22
Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs. Infect Immun (1980) 1.21
Muramyl peptides. Chemical structure, biological activity and mechanism of action. Mol Cell Biochem (1981) 1.19
Structure of iturine A, a peptidolipid antibiotic from Bacillus subtilis. Biochemistry (1978) 1.18
[Mass spectrometry of glycolipids. 2. Natural and synthetic diesters of trehalose]. Eur J Biochem (1967) 1.18
[Studies on the structure and the biosynthesis of specific glycolipids isolated from mycobacteria: mycosides A and B]. Pneumonologie (1970) 1.18
Presence and subcellular localization of two distinct mitogenic fractions in the cells of Nocardia rubra and Nocardia opaca: preparation of soluble mitogenic peptidoglycan fractions. Infect Immun (1976) 1.18
Natural and synthetic trehalose diesters as immunomodulators. Med Res Rev (1986) 1.14
Relationship between chemical structure and adjuvant activity of some synthetic analogues of N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP). Ann Immunol (Paris) (1977) 1.13
Immunotherapy with an intralesionally administered synthetic cord factor analogue. Int J Cancer (1978) 1.11
[On the structure of the alpha-mycolic acids of the human test strain of Mycobacterium tuberculosis]. Bull Soc Chim Fr (1965) 1.10
Parathyroid hormone-dependent degradation of type II Na+/Pi cotransporters. J Biol Chem (1997) 1.10
Nonspecific immunostimulant activities of synthetic trehalose-6,6'-diesters (lower homologs of cord factor). Infect Immun (1978) 1.08
Amoebicidal activity of the antifungal antibiotic sinefungin against Entamoeba histolytica. Trans R Soc Trop Med Hyg (1984) 1.07
Broader geographical spectrum of Cohen syndrome due to COH1 mutations. J Med Genet (2004) 1.07
Phosphorylation of derivatives of the vitamin K group. Vitam Horm (1966) 1.06
Vaccination of rabbits against Entamoeba histolytica with aqueous suspensions of trehalose-dimycolate as the adjuvant. Infect Immun (1985) 1.05
[On the biogenetic origin of the methyl group in position 2 of vitamin K2 of Mycobacterium phlei]. Bull Soc Chim Biol (Paris) (1965) 1.04
Isolation and mass spectrometric identification of the peptide subunits of mycobacterial cell walls. Biochem Biophys Res Commun (1970) 1.04
[The chemical structure of wax D, a macromolecular peptidoglycolipid of human strains of Mycobacterium tuberculosis]. Eur J Biochem (1971) 1.03
In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde. J Infect Dis (1978) 1.03
Past, present and future of the synthetic immunoadjuvant MDP and its analogs. Biochem Pharmacol (1978) 1.02
Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP). Biochem Biophys Res Commun (1978) 1.01
Protective effects of delipidated mycobacterial cells and purified cell walls against Ehrlich carcinoma and a syngeneic lymphoid leukemia in mice. Cancer Res (1973) 1.00
Juvenile rheumatoid arthritis and del(22q11) syndrome: a non-random association. J Med Genet (1998) 0.99
Muramyl peptides. Variation of somnogenic activity with structure. J Exp Med (1984) 0.99
N-methylation of N-acyl oligopeptides. Biochem Biophys Res Commun (1967) 0.99
Cellular mechanisms involved in the acute adaptation of OK cell Na/Pi-cotransport to high- or low-Pi medium. Pflugers Arch (1998) 0.97
Supression of growth of Ehrlich ascites tumor cells in mice pretreated with synthetic analogs of trehalose-6,6-dimycolate (cord factor). J Natl Cancer Inst (1973) 0.96
Biosynthesis of the ethyl side chain of stigmasterol derivatives by the slime mould Dictyostelium discoideum. Tetrahedron Lett (1967) 0.96
Relationship between inhibition of protein methylase I and inhibition of Rous sarcoma virus-induced cell transformation. Cancer Res (1979) 0.96
Inhibition of virus-induced cell transformation by synthetic analogues of S-adenosyl homocysteine. Biochem Biophys Res Commun (1975) 0.95
[Adjuvant activity of peptidoglyoans from mycobacteria]. C R Acad Sci Hebd Seances Acad Sci D (1974) 0.95
Phytosterol biosynthesis: evidence for a 24-ethylidene intermediate during sterol formation in Ochromonas malhamensis. Biochem J (1967) 0.95
Heat-inactivated Sendai virus can enter multiple MHC class I processing pathways and generate cytotoxic T lymphocyte responses in vivo. J Immunol (1995) 0.95
The amino acids of the cell wall of Mycobacterium tuberculosis var. bovis, strain BCG. Presence of a poly(L-glutamic acid). Eur J Biochem (1973) 0.94
Mutations in cytokine receptor-like factor 1 (CRLF1) account for both Crisponi and cold-induced sweating syndromes. Am J Hum Genet (2007) 0.94
Enhancement of immunity against murine syngeneic tumors by a fraction extracted from non-pathogenic mycobacteria. Proc Natl Acad Sci U S A (1975) 0.94
Immunotherapy of an ascitic rat hepatoma with cord factor (trehalose-6, 6'-dimycolate) and synthetic analogues. Int J Cancer (1979) 0.93
Clinical profile of multiple sclerosis in Bengal. Neurol India (1999) 0.93
Biosynthesis of dihydromenaquinone-9 by Mycobacterium phlei. Biochem Biophys Res Commun (1967) 0.92
Prevalence of HFE mutations in people from North Africa living in southern France. Br J Haematol (2001) 0.92
Fetal diagnosis of toxoplasmosis in 190 women infected during pregnancy. Prenat Diagn (1994) 0.91
Immunotherapy of experimental cancer with a mixture of synthetic muramyl dipeptide and trehalose dimycolate. Infect Immun (1981) 0.91
Evidence for a PTH-independent humoral mechanism in post-transplant hypophosphatemia and phosphaturia. Kidney Int (2001) 0.91
Systematic molecular and cytogenetic screening of 100 patients with marfanoid syndromes and intellectual disability. Clin Genet (2013) 0.90
HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5 show significantly lower plasma viral load than wild-type slow progressors. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.90
Lack of evidence for connexin 43 gene mutations in human autosomal recessive lateralization defects. J Mol Cell Cardiol (1997) 0.90
Advantages and limitations of the mass spectrometric sequence determination of permethylated oligopeptide derivatives. Biochem Biophys Res Commun (1968) 0.90
[On the biosynthesis of the ethyl side chain of sterols by the Myxomycete Dictostelium discoileum]. Eur J Biochem (1969) 0.89
Sperm segregation analysis of a (13;22) Robertsonian translocation carrier by FISH: a comparison of locus-specific probe and whole chromosome painting. Hum Reprod (2005) 0.89
Peptidoglycan adjuvants: minimal structure required for activity. Z Immunitatsforsch Exp Klin Immunol (1975) 0.89
The Renpenning syndrome spectrum: new clinical insights supported by 13 new PQBP1-mutated males. Clin Genet (2010) 0.89
Regulation of the renal type IIa Na/Pi cotransporter by cGMP. Pflugers Arch (2001) 0.88
Inhibition of mitogen induced blastogenesis by 5'-deoxy-5'-S-iso-butyl adenosine. Biochem Biophys Res Commun (1976) 0.88
Expression of FMR1, FXR1, and FXR2 genes in human prenatal tissues. J Neuropathol Exp Neurol (1999) 0.88
Synthesis of some new analogs of the immunoadjuvant glycopeptide MDP (N-acetyl-muramyl-L-alanyl-D-isoglutamine). Int J Pept Protein Res (1978) 0.87